GC
BMY icon

Guidance Capital’s Bristol-Myers Squibb BMY Stock Holding History

Guidance Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,205
Closed -$390K – 174
2024
Q2 		$390K Sell
8,205
-1,734
-17% -$77.6K 0.13% 148
2024
Q1 		$482K Sell
9,939
-815
-8% -$41.5K 0.18% 123
2023
Q4 		$567K Buy
10,754
+1,559
+17% +$81.8K 0.23% 99
2023
Q3 		$526K Buy
9,195
+21
+0.2% +$1.29K 0.24% 87
2023
Q2 		$562K Buy
+9,174
New +$615K 0.24% 79

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Guidance Capital's BMY Position: Q3 2024 in Review

Guidance Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 8,205 shares — an estimated $390K sold.

Guidance Capital first reported a position in BMY in Q2 2023 and held it in 5 quarters. The position peaked at $567K in Q4 2023. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Guidance Capital reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Guidance Capital sold 8,205 Bristol-Myers Squibb shares in Q3 2024, an estimated $390K.
  • Guidance Capital first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 5 quarters.
  • Guidance Capital's Bristol-Myers Squibb position peaked at $567K in Q4 2023.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Guidance Capital's 13F filing for Q3 2024, filed 22 Oct 2024.